Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PGEM
5326
DELISTED
Ply Gem Holdings, Inc.
PGEM
| $136K | ﹤0.01% |
11,583
-272,212
| -96% | -$3.5M |
2013 Q4
6 quarters
|
|
|
ANR
5327
DELISTED
Alpha Natural Resources Inc
ANR
| $135K | ﹤0.01% |
447,116
+341,410
| +323% | +$235K |
2013 Q2
8 quarters
|
|
5328
DELISTED
Cross Country Healthcare
CCRN
| $134K | ﹤0.01% |
10,612
-10,242
| -49% | -$116K |
2013 Q2
8 quarters
|
|
|
CNCE
5329
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $134K | ﹤0.01% |
9,023
-5,500
| -38% | -$83.8K |
2014 Q1
5 quarters
|
|
|
JFC
5330
DELISTED
JPMorgan China Region Fund, Inc.
JFC
| $134K | ﹤0.01% |
7,128
-467
| -6% | -$9.34K |
2013 Q4
6 quarters
|
|
|
EVJ
5331
DELISTED
Eaton Vance New Jersey Municipal Income Trust
EVJ
| $134K | ﹤0.01% |
11,500
| – | – |
2013 Q2
8 quarters
|
|
5332
Global Net Lease
GNL
$1.72B
| $133K | ﹤0.01% |
+5,000
| New | +$136K |
2015 Q2
0 quarters
|
|
5333
ProShares Ultra Health Care
RXL
$102M
| $133K | ﹤0.01% |
7,120
+3,920
| +123% | +$71.5K |
2013 Q4
6 quarters
|
|
|
WG
5334
DELISTED
Willbros Group
WG
| $133K | ﹤0.01% |
103,264
-64,847
| -39% | -$144K |
2013 Q2
8 quarters
|
|
5335
Nuwellis
NUWE
$1.74M
| – | – |
0
| – | – |
2013 Q4
6 quarters
|
|
5336
Platinum Group Metals
PLG
$148M
| $132K | ﹤0.01% |
3,294
+1,095
| +50% | +$50.8K |
2013 Q4
6 quarters
|
|
5337
VOC Energy
VOC
$57.8M
| $132K | ﹤0.01% |
23,186
-24,416
| -51% | -$143K |
2013 Q2
8 quarters
|
|
5338
Chefs' Warehouse
CHEF
$4.56B
| $131K | ﹤0.01% |
6,197
+3,504
| +130% | +$70K |
2013 Q2
8 quarters
|
|
|
PYN
5339
DELISTED
PIMCO New York Municipal Income Fund III
PYN
| $131K | ﹤0.01% |
14,127
| – | – |
2013 Q2
8 quarters
|
|
|
LABC
5340
DELISTED
LOUISIANA BANCORP INC COM STK NEW (LA)
LABC
| $131K | ﹤0.01% |
5,505
| – | – |
2013 Q4
6 quarters
|
|
|
TREC
5341
DELISTED
Trecora Resources
TREC
| $130K | ﹤0.01% |
8,599
-59,595
| -87% | -$774K |
2014 Q3
3 quarters
|
|
5342
LifeVantage
LFVN
$76.2M
| $129K | ﹤0.01% |
34,880
-18,546
| -35% | -$85.7K |
2013 Q2
8 quarters
|
|
5343
Parke Bancorp
PKBK
$381M
| $129K | ﹤0.01% |
14,787
+1,322
| +10% | +$11.4K |
2013 Q4
6 quarters
|
|
|
IBCC
5344
DELISTED
iShares iBonds Mar 2018 Term Corporate ex-Financials ETF
IBCC
| $129K | ﹤0.01% |
5,180
+1,260
| +32% | +$31.4K |
2014 Q2
4 quarters
|
|
|
TRIV
5345
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
| $129K | ﹤0.01% |
24,084
+1,273
| +6% | +$9.03K |
2014 Q2
4 quarters
|
|
5346
Aldeyra Therapeutics
ALDX
$41.2M
| $128K | ﹤0.01% |
16,504
+2,663
| +19% | +$23K |
2014 Q4
2 quarters
|
|
5347
Farmers National Banc Corp
FMNB
$905M
| $128K | ﹤0.01% |
15,600
+912
| +6% | +$7.46K |
2013 Q2
8 quarters
|
|
5348
Iovance Biotherapeutics
IOVA
$6.18B
| $128K | ﹤0.01% |
13,919
+410
| +3% | +$4.58K |
2015 Q1
1 quarter
|
|
5349
Woori Financial
WF
$17.3B
| $128K | ﹤0.01% |
4,839
+2,000
| +70% | +$56.3K |
2013 Q4
6 quarters
|
|
5350
Alerian Energy Infrastructure ETF
ENFR
$541M
| $127K | ﹤0.01% |
5,000
-3,486
| -41% | -$94.5K |
2014 Q4
2 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.